chlorpromazine has been researched along with fsl-1 lipoprotein, synthetic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasebe, A; Iyori, M; Kiura, K; Ohtani, M; Shamsul, HM; Shibata, K; Totsuka, Y; Zhang, D | 1 |
| Astudillo, H; Baeza, I; España, L; Estrada-García, I; Estrada-Parra, S; Flores-Romo, L; Landa, C; Reséndiz, A; Serafín-López, J; Tescucano, A; Wong, C; Wong-Baeza, C | 1 |
2 other study(ies) available for chlorpromazine and fsl-1 lipoprotein, synthetic
| Article | Year |
|---|---|
The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2.
Topics: Animals; CD36 Antigens; Cell Line; Chlorpromazine; Clathrin; Diglycerides; Dopamine Antagonists; Dose-Response Relationship, Drug; Endocytosis; Humans; Ionophores; Lipopolysaccharide Receptors; Macrophages, Peritoneal; Membrane Microdomains; Mice; Mice, Knockout; Nystatin; Oligopeptides; Toll-Like Receptor 2 | 2010 |
Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.
Topics: Animals; Autoantibodies; Chlorpromazine; Cytokines; Diglycerides; Disease Models, Animal; Female; Flagellin; Gene Expression Regulation; HEK293 Cells; Humans; Immunoglobulin G; Immunoglobulin M; Inflammation; Lipopolysaccharides; Liposomes; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Oligopeptides; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylserines; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 6 | 2015 |